RedHill Biopharma entered into a commercialization agreement with ParaPRO to promote RedHill's Esomeprazole Strontium Delayed-Release capsules.
Here's what you should know:
1. The capsules are proton pump inhibitors used to treat gastroesophageal reflux disease. They also reduce the risk of duodenal ulcer nonsteroidal anti-inflammatory drug-associated gastric ulcers.
2. The product can be marketed to gastroenterologists in select U.S. areas.
3. Redhill believes promotion will begin in the next few weeks.
4. This is RedHill's third U.S.-based product.